Ads
related to: abbvie upadacitinib
AbbVie's (ABBV) Rinvoq Dermatitis sNDA Review Gets Delayed
Zacks via Yahoo Finance· 2 weeks agoAbbVie ABBV announced that the FDA has extended the review period for a supplemental new drug...
AbbVie (ABBV) Seeks Skyrizi Approval for Psoriatic Arthritis
Zacks via Yahoo Finance· 1 week agoAbbVie Inc. ABBV announced that it has submitted regulatory applications to the FDA and the European...
AbbVie's (ABBV) Q1 Earnings and Sales Surpass Estimates
Zacks via Yahoo Finance· 12 months agoMeanwhile, the company's revenues of $8.62 billion beat the Zacks Consensus Estimate of $8.44...
AbbVie's (ABBV) Rinvoq Gets CHMP Nod for Two New Indications
Zacks via Yahoo Finance· 4 months agoAbbVie Inc. ABBV announced that the Committee for Medicinal Products for Human Use (“CHMP”) of the...
AbbVie Seeks US and EU Nods for Rinvoq for Psoriatic Arthritis
Zacks via Yahoo Finance· 11 months agoAbbVie Inc. ABBV announced that it has submitted regulatory applications both to the FDA and the...
Why AbbVie Is a Retiree's Dream Stock
Motley Fool via Yahoo Finance· 2 years agoRetired investors would also want to make sure that the company was in good shape to keep those dividends flowing, with dividend growth a nice bonus....
The Zacks Analyst Blog Highlights: AbbVie, Eagle Bancorp Montana, H&R Block, Mackinac Financial and...
Zacks via Yahoo Finance· 10 months agoEvery day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and...
AbbVie’s Rinvoq Beats Bristol-Myers’ Orencia In New Rheumatoid Arthritis DatA
SmarterAnalyst via Yahoo Finance· 10 months agoBiopharma AbbVie (ABBV) has announced positive Phase 3 data from a Select-Choice clinical trial,...
AbbVie prices new rheumatoid arthritis drug at $59,000 a year
Reuters via Yahoo News· 2 years agoHumira brought in global revenue of $4.87 billion in the second quarter, but sales have been hit by...
AbbVie Seeks Rinvoq Approval For Psoriatic Arthritis In US, Europe
SmarterAnalyst via Yahoo Finance· 11 months agoDrugmaker AbbVie (ABBV) has announced that it has submitted applications for a new indication for...
Ads
related to: abbvie upadacitinib
